Notice Number: NOT-HL-20-748

Key Dates
Release Date: January 10, 2020

Issued by
National Heart, Lung, and Blood Institute (NHLBI)

Purpose

The National Heart, Lung, and Blood Institute (NHLBI) issued a Funding Opportunity Announcement (FOA) on November 19, 2019: RFA-HL-21-011 "Stimulating T4 Implementation Research to Optimize Integration of Proven-effective Interventions for Heart, Lung, and Blood Diseases and Sleep Disorders into Practice (STIMULATE-2) (R61/R33 Clinical Trial Required).

A pre-submission technical assistance webinar is being offered to inform potential applicants about RFA-HL-21-011 (STIMULATE-2)(R61/R33)) and will include a review of the purpose and objectives of the FOA, application and peer review requirements, and budget considerations.

All prospective applicants are invited to attend and are strongly encouraged to send relevant questions prior to the webinar to maximize the use of time. Questions should be sent by email to [email protected] by February 28, 2020.

Session date and time:

Wednesday, March 18, 2020 at 12:30 pm EST

Join Webex Meeting

Event password: CTRIS123
Number (US/Canada): 1-650-479-3208
Meeting Number/Access code: 625 745 908

Event address for attendees: https://nih.webex.com/webappng/sites/nih/meeting/info/148659073340963817?MTID=m65d62a4d47a3e45845608341625dc305

Participation in this webinar, although encouraged, is optional and is not required for the submission of an application in response to RFA-HL-21-011. Responses to questions will be posted on an Frequently Asked Questions (FAQs) page on the NHLBI Website soon thereafter; search by the RFA number (RFA-HL-21-011).

Inquiries

Please direct all inquiries to:

Rebecca A. Roper, MS, MPH
National Heart, Lung, and Blood Institute (NHLBI)
Telephone: 301-451-1051
Email: [email protected]